Jiangxi Synergy Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Jiangxi Synergy Pharmaceutical has a total shareholder equity of CN¥2.3B and total debt of CN¥745.9M, which brings its debt-to-equity ratio to 32.3%. Its total assets and total liabilities are CN¥3.3B and CN¥985.7M respectively. Jiangxi Synergy Pharmaceutical's EBIT is CN¥108.6M making its interest coverage ratio -7. It has cash and short-term investments of CN¥308.0M.
Key information
32.3%
Debt to equity ratio
CN¥745.86m
Debt
| Interest coverage ratio | -7x |
| Cash | CN¥307.96m |
| Equity | CN¥2.31b |
| Total liabilities | CN¥985.72m |
| Total assets | CN¥3.30b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300636's short term assets (CN¥995.4M) exceed its short term liabilities (CN¥536.4M).
Long Term Liabilities: 300636's short term assets (CN¥995.4M) exceed its long term liabilities (CN¥449.3M).
Debt to Equity History and Analysis
Debt Level: 300636's net debt to equity ratio (19%) is considered satisfactory.
Reducing Debt: 300636's debt to equity ratio has increased from 18.4% to 32.3% over the past 5 years.
Debt Coverage: 300636's debt is well covered by operating cash flow (29.5%).
Interest Coverage: 300636 earns more interest than it pays, so coverage of interest payments is not a concern.